Hepatorenal Syndrome Treatment Market Share

Market Share of Hepatorenal Syndrome Treatment Industry

The hepatorenal syndrome treatment market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Cumberland Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, New Medicon Pharma Lab, Becton, Dickinson and Company, Edwards Lifesciences Corporation, Aetna Inc.,Baxter, Fuji Systems Corp, Johnson & Johnson Co, G Surgiwear Ltd.

Hepatorenal Syndrome Treatment Market Leaders

1. Cumberland Pharmaceuticals Inc.

2. Mallinckrodt Pharmaceuticals

3. New Medicon Pharma Lab

4. Becton, Dickinson and Company

5. Edwards Lifesciences Corporation

*Disclaimer: Major Players sorted in no particular order